NeuroPace (NPCE)
(Delayed Data from NSDQ)
$14.10 USD
+0.12 (0.86%)
Updated Apr 22, 2024 11:51 AM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Balance Sheet
Fiscal Year End for NeuroPace, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 66 | 77 | 116 | 38 | 5 |
Receivables | 12 | 7 | 7 | 8 | 6 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 11 | 10 | 8 | 7 | 8 |
Other Current Assets | 3 | 3 | 2 | 1 | 1 |
Total Current Assets | 93 | 98 | 133 | 55 | 20 |
Net Property & Equipment | 1 | 1 | 1 | 1 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 108 | 114 | 134 | 56 | 21 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 2 | 63 |
Accounts Payable | 2 | 2 | 1 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 11 | 7 | 8 | 7 | 7 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 0 | 0 | 0 | 5 |
Total Current Liabilities | 16 | 11 | 9 | 10 | 75 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 1 | 1 | 2 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 57 | 53 | 50 | 51 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 142 | 74 |
Total Liabilities | 87 | 79 | 60 | 204 | 150 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 524 | 507 | 498 | 240 | 234 |
Retained Earnings | -504 | -471 | -424 | -388 | -364 |
Other Equity | 0 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 21 | 35 | 74 | -148 | -129 |
Total Liabilities & Shareholder's Equity | 108 | 114 | 134 | 56 | 21 |
Total Common Equity | 21 | 35 | 74 | -148 | -129 |
Shares Outstanding | 26.20 | 24.90 | 24.30 | NA | NA |
Book Value Per Share | 0.79 | 1.40 | 3.02 | 0.00 | 0.00 |
Fiscal Year End for NeuroPace, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 66 | 61 | 64 | 68 |
Receivables | NA | 12 | 11 | 11 | 9 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 11 | 10 | 10 | 11 |
Other Current Assets | NA | 3 | 2 | 2 | 3 |
Total Current Assets | NA | 93 | 84 | 87 | 90 |
Net Property & Equipment | NA | 1 | 1 | 1 | 1 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 108 | 99 | 102 | 106 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 1 | 2 | 2 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 11 | 10 | 8 | 7 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 1 | 0 | 0 | 0 |
Total Current Liabilities | NA | 16 | 13 | 12 | 10 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 57 | 56 | 55 | 54 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 87 | 83 | 81 | 79 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 524 | 514 | 512 | 509 |
Retained Earnings | NA | -504 | -498 | -490 | -481 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 21 | 16 | 21 | 27 |
Total Liabilities & Shareholder's Equity | NA | 108 | 99 | 102 | 106 |
Total Common Equity | 0 | 21 | 16 | 21 | 27 |
Shares Outstanding | 26.20 | 26.20 | 25.80 | 25.40 | 25.30 |
Book Value Per Share | 0.00 | 0.79 | 0.63 | 0.84 | 1.09 |